IN THE SENATE OF THE UNITED STATES
January 6, 2015
Mrs. Feinstein (for herself, Mr. Udall, Mr. Blumenthal, Ms. Klobuchar, Mr. Grassley, and Ms. Heitkamp) introduced the following bill; which was read twice and referred to the Committee on Finance
January 13, 2015
Committee discharged; referred to the Committee on the Judiciary
To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.
This Act may be cited as the
Transnational Drug Trafficking Act of 2015.
Possession, manufacture or distribution for purposes of unlawful importations
Section 1009 of the Controlled Substances Import and Export Act (21 U.S.C. 959) is amended—
by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and
in subsection (a), by striking
It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States.
It shall be unlawful for any person to manufacture or distribute a listed chemical—
intending or knowing that the listed chemical will be used to manufacture a controlled substance; and
intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States.
Trafficking in counterfeit goods or services
Chapter 113 of title 18, United States Code, is amended—
in section 2318(b)(2), by striking
section 2320(e) and inserting
section 2320(f); and
in section 2320—
in subsection (a), by striking paragraph (4) and inserting the following:
traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug,
in subsection (b)(3), in the matter preceding subparagraph (A), by striking
counterfeit drug and inserting
drug that uses a counterfeit mark on or in connection with the drug; and
in subsection (f), by striking paragraph (6) and inserting the following:
the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321).